- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Staging IV NSCLC in China
Totalt 666 resultater
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Rekruttering
-
Hunan Province Tumor HospitalRekruttering
-
Hunan Province Tumor HospitalFullført
-
Suzhou Municipal HospitalFullført
-
Zhejiang Cancer HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.; Innovent Biologics (Suzhou)...Ukjent
-
Hebei Medical University Fourth HospitalUkjent
-
Henan Provincial People's HospitalUkjent
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Ukjent
-
InxMed (Shanghai) Co., Ltd.Rekruttering
-
Li Zhang, MDRekrutteringDiagnosen var ALK-positiv NSCLC | Andre generasjon ALK-TKI er motstandsdyktig | Effekten av ensatinib i denne undergruppen av pasienterKina
-
RemeGen Co., Ltd.Rekruttering
-
Shanghai Junshi Bioscience Co., Ltd.Fullført
-
Tianjin Medical University Cancer Institute and...UkjentKarsinom bryststadium IVKina
-
Henan Cancer HospitalTilbaketrukket
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RekrutteringNSCLC | EGFR-genmutasjonKina
-
Convalife (Shanghai) Co., Ltd.Har ikke rekruttert ennå
-
Wuhan Union Hospital, ChinaRekruttering
-
AkesoRekruttering
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Ukjent
-
Henan Cancer HospitalHar ikke rekruttert ennå
-
Base Therapeutics (Shanghai) Co., Ltd.The General Hospital of Eastern Theater CommandRekruttering
-
Biotheus Inc.Rekruttering
-
Guangzhou Institute of Respiratory DiseaseGeneCast Biotechnology Co., Ltd.Ukjent
-
Tongji HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.Ukjent
-
Guangdong Association of Clinical TrialsUkjent
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Ukjent
-
Tianjin Medical University Cancer Institute and...RekrutteringNSCLC | Kirurgi | StrålebehandlingKina
-
The Affiliated Hospital of Qingdao UniversityFullførtNSCLC | Angiogenese | ImmunterapiKina
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRekrutteringStereotaktisk kroppsstrålebehandling; PD-1-hemmer; Hypertermi; NSCLCKina
-
Shanghai Henlius BiotechRekruttering
-
Lunxu LiuAvsluttet
-
Xinqiao Hospital of ChongqingXuzhou Medical UniversityUkjentTilbakevendende voksent diffust storcellet lymfom | Tilbakevendende mantelcellelymfom | Tilbakevendende follikulært lymfom | Stadium III/IV Voksen diffust storcellet lymfom | Stadium III/IV follikulært lymfom | Stadium III/IV MantelcellelymfomKina
-
Hebei Senlang Biotechnology Inc., Ltd.RekrutteringSarkom | Livmorhalskreft | NSCLC | Solid svulst, voksenKina
-
Fudan UniversityUkjent
-
PfizerFullførtALK-positiv ikke-småcellet lungekreft (NSCLC) og ROS1-positiv NSCLCForente stater, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republikken, Spania, Belgia, Sveits, Frankrike, Tyskland, Hong Kong, Italia
-
Northern Jiangsu Province People's HospitalRekruttering
-
Energenx Medical LTD.Rekruttering
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Rekruttering
-
Henan Cancer HospitalCttqUkjent
-
Hutchison Medipharma LimitedFullført
-
Nanfang Hospital of Southern Medical UniversityUkjent
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGeneRekruttering
-
Hubei Cancer HospitalPåmelding etter invitasjon
-
First Affiliated Hospital Xi'an Jiaotong UniversityTang-Du Hospital; Yan'an University Affiliated HospitalUkjentIkke-plateepitel NSCLCKina
-
Peking University Cancer Hospital & InstituteGeneplus-Beijing Co. Ltd.Rekruttering
-
Shanghai Chest HospitalShanghai Junshi Bioscience Co., Ltd.Rekruttering
-
Betta Pharmaceuticals Co., Ltd.Ukjent
-
Shanghai Chest HospitalUkjent
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRekrutteringIkke-plateepitel NSCLCKina